Eagle’s Eye View: Do Age or Sex Affect the Outcome of Patients with Heart Failure with Reduced Ejection Fraction?
In this week’s View, Dr. Eagle explores the impact of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on the recurrence of atrial fibrillation after catheter ablation in patients with type-2 diabetes, then discusses the differences and similarities between the ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases. Finally, Dr. Eagle looks at data from the VICTORIA Trial and asks whether age or sex affect the outcome of patients with heart failure with reduced ejection fraction.
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Valvular Heart Disease, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, EP Basic Science, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and VHD, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Imaging, Interventions and Structural Heart Disease, Mitral Regurgitation, Acute Coronary Syndromes, Vascular Medicine
Keywords: EaglesEyeView, Ablation Techniques, Anti-Arrhythmia Agents, Arrhythmias, Cardiac, Atrial Fibrillation, Catheter Ablation, Diabetes Mellitus, Type 2, Electric Countershock, Heart Failure, Recurrence, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Aortic Valve Insufficiency, Cardiac Surgical Procedures, Coronary Artery Bypass, Diagnostic Imaging, Diagnostic Imaging, Heart Valve Diseases, Heart Valve Prosthesis, Mitral Valve Insufficiency, Stroke Volume, Transcatheter Aortic Valve Replacement, Ventricular Function, acc20, ACC Annual Scientific Session, Blood Pressure, Diuretics, Geriatrics, Guanosine Monophosphate, Hemoglobins, Natriuretic Peptide, Brain, Peptide Fragments, Secondary Prevention, Vascular Diseases
< Back to Listings